NRP vs DHOPE vs COR-NMP in ECD-DCD Donation

Recruiting Observational Study
Liver Transplant Organ Perfusion Complication of Surgical Procedure
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 75
Sex
Any
Study type
Observational
Participants needed
150 (estimated)
Sponsor
Erasmus Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
There is still a discrepancy between the number of liver transplant candidates and the availability of liver grafts, resulting in waiting list mortality. To increase the supply of suitable liver grafts, extended-donor criteria allografts can be used. However, in the case of donation after cardiac death this is not without a risk. Donor after cardiac death (DCD) grafts have increased risk of primar…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * DCD donor (Maastricht type III and V) * Age above 50 years old and below 75 years old Exclusion criteria: * Malignancy (except for primary non-metastatic central nervous system tumors, non-melanoma skin tumors or cured malignancies) * Active infection (sepsis, meningitis, hu…
Contacts

Jeroen de Jonge, Dr.

+31643904182

j.dejonge.1@erasmusmc.nl

CONTACT

Fenna J van der Heijden, Drs.

+31638406398

f.vanderheijden@erasmusmc.nl

CONTACT